Curigliano G, Mueller V, Borges V, Hamilton E, et al. Corrigendum to "Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis": [Annals of Oncology 33 (2022) 3 Ann Oncol 2022 Dec 21:S0923-7534(22)04773-1. doi: 10.1016/j.annonc.2022.
PMID: 36564285